This video was made by McMaster students Shefali Verma, Shilpa Tandon, and Niki Sadat Afjeh in collaboration with the McMaster Demystifying Medicine Program.
————————————
Copyright McMaster University 2020
————————————
SUBSCRIBE AND FOLLOW US FOR MORE CONTENT:
Youtube: @Demystifying Medicine
Twitter: @McMasterDMS- https://twitter.com/McMasterDMS Website: https://healthsci.mcmaster.ca/demysti…
Podcasts: @MacDemystMed- https://soundcloud.com/user-781345766 Instagram: @demystifying_medicine
References:
Gibbs, M., Winsper, C., Marwaha, S., Gilbert, E., Broome, M., & Singh, S. P. (2015). Cannabis use and mania symptoms: a systematic review and meta-analysis. Journal of affective disorders, 171, 39–47. https://doi.org/10.1016/j.jad.2014.09.016
Grinspoon, Peter. “Medical Marijuana.” Harvard Health Blog, 15 Apr. 2020, www.health.harvard.edu/blog/medical-marijuana-2018011513085.
Hall, W., & Solowij, N. (1998). Adverse effects of cannabis. The Lancet, 352(9140), 1611-1616. Hartman, R. L., & Huestis, M. A. (2013). Cannabis effects on driving skills. Clinical chemistry,
59(3), 478–492. https://doi.org/10.1373/clinchem.2012.194381
Hunt, G. E., Malhi, G. S., Cleary, M., Lai, H. M., & Sitharthan, T. (2016). Prevalence of comorbid bipolar and substance use disorders in clinical settings, 1990-2015: Systematic review and meta-analysis. Journal of affective disorders, 206, 331–349. https://doi.org/10.1016/j.jad.2016.07.011
Kedzior, K. K., & Laeber, L. T. (2014). A positive association between anxiety disorders and cannabis use or cannabis use disorders in the general population–a meta-analysis of 31 studies. BMC psychiatry, 14, 136. https://doi.org/10.1186/1471-244X-14-136
Lev-Ran, S., Roerecke, M., Le Foll, B., George, T., McKenzie, K., & Rehm, J. (2014). The association between cannabis use and depression: A systematic review and meta-analysis of longitudinal studies. Psychological Medicine, 44(4), 797-810. doi:10.1017/S0033291713001438
Lloyd, S. L., & Striley, C. W. (2018). Marijuana Use Among Adults 50 Years or Older in the 21st Century. Gerontology & geriatric medicine, 4, 2333721418781668. https://doi.org/10.1177/2333721418781668
Mönckeberg B F. (2014). Los pro y contra de la legalización de la marihuana [Pros and cons of legalizing marijuana]. Revista chilena de pediatria, 85(2), 229–237. https://doi.org/10.4067/S0370-41062014000200014
NIDA. 2020, April 8. Is marijuana a gateway drug?. Retrieved from https://www.drugabuse.gov/publications/research-reports/marijuana/marijuana-gateway-drug on 2020, November 15
Regier, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L., & Goodwin, F. K. (1990). Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA, 264(19), 2511–2518.
Statista. “Marijuana Consumption by Age Canada 2019.” Statista, 2 Sept. 2020, www.statista.com/statistics/587705/marijuana-consumption-canada-by-age/.
Shrivastava, A., Johnston, M., Terpstra, K., & Bureau, Y. (2014). Cannabis and psychosis: Neurobiology. Indian journal of psychiatry, 56( 1), 8–16. https://doi.org/10.4103/0019-5545.124708
The Ministry of Health. “Health Effects of Cannabis.” Government of Canada, 2017, www.canada.ca/content/dam/hc-sc/documents/services/campaigns/27-16-1808-Factsheet-Health- Effects-eng-web.pdf.
